BridgeMD
Tests treatment safety and results for Type 2 Diabetes
Official title HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
ClinicalTrials.gov ID: NCT07546929
What this study is testing
What is HP-211?
HP-211 is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for type 2 diabetes.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Blood sugar levels are controlled by insulin, a hormone made by cells in the pancreas. After a meal, carbohydrates are broken down into glucose which is absorbed from the intestine into the blood leading to a rise in glucose (blood sugar) which triggers the secretion of insulin.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Have type 2 diabetes for greater than 3 months and no longer than 5 years by history prior to entering the trial, based upon ADA disease diagnostic...
- Have an HbA1c \> 6.5% and ≤ 10% as determined by the central lab at Visit 1 (Screening).
- Have been on a stable maximum dose of metformin for at least 3 months prior to entering the study or have been on stable therapy of diet and exercise...
You likely can't join if
- Have known type 1 diabetes.
- Diabetic complications
- Have taken any oral (other than metformin) or injectable treatment (insulin or GLP-1 RA classes or other) for type 2 diabetes currently or for...
- Systolic blood pressure greater than 150 mmHg or a diastolic blood pressure greater than 100 mmHg at Visit 1 on average after three supine...
- At baseline, the QT interval corrected by Fridericia (QTcF) ECG findings (\>450 msec for males and \>470 msec for females), left bundle branch block...
The study team makes the final eligibility decision.
Where it's taking place
- Canoga Park, California, United States
- Doral, Florida, United States
- Edgewater, Florida, United States
- Fort Myers, Florida, United States
- Miami, Florida, United States
- Miramar, Florida, United States
- Cordele, Georgia, United States
- El Dorado, Kansas, United States
- Marrero, Louisiana, United States
- Troy, Michigan, United States
- Norfolk, Nebraska, United States
- Las Vegas, Nevada, United States
- Canton, Ohio, United States
- Maumee, Ohio, United States
- East Greenwich, Rhode Island, United States
- Dallas, Texas, United States
- Irving, Texas, United States
- Lewisville, Texas, United States
- McKinney, Texas, United States
- San Antonio, Texas, United States
+ 4 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Canoga Park, California, United States; Doral, Florida, United States; Edgewater, Florida, United States; Fort Myers, Florida, United States; Miami, Florida, United States; Miramar, Florida, United States and 18 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.